Demant EPS - Earnings per Share 2012-2025 | WILYY
Demant annual and quarterly earnings per share history from 2012 to 2025. Earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.
- Demant EPS for the quarter ending June 30, 2025 was $0.00, a 0% increase year-over-year.
- Demant EPS for the twelve months ending June 30, 2025 was $0.00, a 0% increase year-over-year.
- Demant 2024 annual EPS was $0.78, a 33.56% increase from 2023.
- Demant 2023 annual EPS was $0.58, a 10.43% decline from 2022.
- Demant 2022 annual EPS was $0.65, a 23.38% decline from 2021.
| Demant Annual EPS | |
|---|---|
| 2024 | $0.78 |
| 2023 | $0.58 |
| 2022 | $0.65 |
| 2021 | $0.85 |
| 2020 | $0.36 |
| 2019 | $0.45 |
| 2018 | $0.58 |
| 2017 | $0.52 |
| 2016 | $0.41 |
| 2015 | $0.99 |
| 2014 | $0.43 |
| 2013 | $0.41 |
| 2012 | $0.35 |
| 2011 | $0.39 |
| Demant Quarterly EPS | |
|---|---|
| 2025-06-30 | $0.00 |
| 2024-12-31 | $0.00 |
| 2024-06-30 | $0.00 |
| 2023-12-31 | $0.00 |
| 2023-06-30 | $0.00 |
| 2022-12-31 | $0.00 |
| 2022-06-30 | $0.00 |
| 2021-12-31 | $0.00 |
| 2021-06-30 | $0.00 |
| 2020-12-31 | $0.00 |
| 2020-06-30 | $0.00 |
| 2019-12-31 | $0.00 |
| 2019-06-30 | $0.00 |
| 2018-12-31 | $0.00 |
| 2018-06-30 | $0.00 |
| 2017-12-31 | $0.00 |
| 2017-06-30 | $0.00 |
| 2016-12-31 | $0.00 |
| 2016-06-30 | $0.00 |
| 2015-12-31 | $0.00 |
| 2014-06-30 | $0.00 |
| 2013-12-31 | $0.00 |
| 2013-06-30 | $0.00 |
| 2012-12-31 | $0.00 |
| 2012-06-30 | $0.00 |
| 2011-12-31 | $0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $7.372B | $3.252B |
| Demant A/S is engaged in the healthcare industry. It develops, manufactures and sells products and equipment designed to aid the hearing and communication of individuals. The company's business area consists of Hearing Devices, Hearing Implants, Diagnostic Instruments and Personal Communication. Demant A/S, formerly known as William Demant Holding A/S, is based in Smorum, Denmark. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $216.733B | 24.98 |
| EssilorLuxottica (ESLOY) | France | $149.439B | 0.00 |
| Boston Scientific (BSX) | United States | $141.899B | 32.45 |
| Stryker (SYK) | United States | $138.196B | 27.44 |
| Medtronic (MDT) | Ireland | $124.291B | 17.22 |
| Medline (MDLN) | United States | $56.122B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $49.743B | 0.00 |
| Agilent Technologies (A) | United States | $41.955B | 26.52 |
| GE HealthCare Technologies (GEHC) | United States | $39.585B | 18.93 |
| ResMed (RMD) | United States | $37.629B | 26.04 |
| Koninklijke Philips (PHG) | Netherlands | $28.695B | 18.74 |
| Terumo (TRUMY) | Japan | $21.868B | 24.62 |
| Insulet (PODD) | United States | $19.595B | 60.82 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.124B | 11.30 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $14.309B | 0.00 |
| Baxter (BAX) | United States | $10.358B | 8.36 |
| Sunny Optical Technology (SNPTF) | China | $9.589B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $8.713B | 31.33 |
| BillionToOne (BLLN) | United States | $4.538B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $4.475B | 13.63 |
| Haemonetics (HAE) | United States | $3.881B | 17.27 |
| Envista Holdings (NVST) | United States | $3.844B | 22.06 |
| ICU Medical (ICUI) | United States | $3.732B | 23.70 |
| Prestige Consumer Healthcare (PBH) | United States | $3.140B | 14.32 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.099B | 0.00 |
| QuidelOrtho (QDEL) | United States | $2.266B | 14.57 |
| Perrigo (PRGO) | Ireland | $2.056B | 5.15 |
| Neogen (NEOG) | United States | $2.038B | 44.62 |
| LeMaitre Vascular (LMAT) | United States | $1.902B | 38.28 |
| AtriCure (ATRC) | United States | $1.871B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $1.845B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.819B | 79.73 |
| Phibro Animal Health (PAHC) | United States | $1.614B | 16.13 |
| Lumexa Imaging Holdings (LMRI) | United States | $1.496B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.436B | 20.78 |
| Kestra Medical Technologies (KMTS) | United States | $1.366B | 0.00 |
| BioLife Solutions (BLFS) | United States | $1.157B | 343.43 |
| Capricor Therapeutics (CAPR) | United States | $1.121B | 0.00 |
| Tilray Brands (TLRY) | Canada | $1.044B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $1.007B | 0.00 |
| InMode (INMD) | Israel | $0.916B | 10.35 |
| Omeros (OMER) | United States | $0.909B | 0.00 |
| CeriBell (CBLL) | United States | $0.869B | 0.00 |
| Valneva SE (VALN) | France | $0.840B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.558B | 15.12 |
| Cresco Labs (CRLBF) | United States | $0.497B | 0.00 |
| Verano Holdings (VRNO) | United States | $0.489B | 0.00 |
| Brainsway (BWAY) | Israel | $0.474B | 80.63 |
| Canopy Growth (CGC) | Canada | $0.453B | 0.00 |
| SNDL (SNDL) | Canada | $0.436B | 0.00 |
| Cerus (CERS) | United States | $0.436B | 0.00 |
| Evolus (EOLS) | United States | $0.374B | 0.00 |
| Quanterix (QTRX) | United States | $0.344B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.317B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.293B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.278B | 22.12 |
| TerrAscend (TSNDF) | Canada | $0.259B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.252B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.241B | 142.00 |
| High Tide (HITI) | Canada | $0.238B | 0.00 |
| Organigram Global (OGI) | Canada | $0.232B | 0.00 |
| Owens & Minor (OMI) | United States | $0.217B | 2.17 |
| Sanara MedTech (SMTI) | United States | $0.213B | 0.00 |
| Accendra Health (ACH) | United States | $0.207B | 2.08 |
| Vireo Growth (VREOF) | United States | $0.204B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.193B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.192B | 16.92 |
| Quipt Home Medical (QIPT) | United States | $0.154B | 0.00 |
| Apyx Medical (APYX) | United States | $0.153B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.146B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.137B | 0.00 |
| Exagen (XGN) | United States | $0.135B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.120B | 0.00 |
| Fonar (FONR) | United States | $0.115B | 16.75 |
| Biote (BTMD) | United States | $0.115B | 5.02 |
| MacroGenics (MGNX) | United States | $0.113B | 0.00 |
| ImmuCell (ICCC) | United States | $0.060B | 25.65 |
| Sharps Technology (STSS) | United States | $0.059B | 0.00 |
| Nephros (NEPH) | United States | $0.048B | 34.92 |
| Cytosorbents (CTSO) | United States | $0.044B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.039B | 0.00 |
| Jin Medical (ZJYL) | China | $0.039B | 0.00 |
| Modular Medical (MODD) | United States | $0.037B | 0.00 |
| Veru (VERU) | United States | $0.036B | 0.00 |
| United-Guardian (UG) | United States | $0.029B | 14.47 |
| Allurion Technologies (ALUR) | United States | $0.017B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.016B | 0.00 |
| Bonk (BNKK) | United States | $0.015B | 0.00 |
| INLIF (INLF) | China | $0.009B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.009B | 0.00 |
| Flora Growth (FLGC) | United States | $0.007B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.007B | 0.00 |
| Zynex (ZYXI) | United States | $0.004B | 0.00 |
| Agape ATP (ATPC) | $0.004B | 0.00 | |
| GlucoTrack (GCTK) | United States | $0.003B | 0.00 |
| Functional Brands (MEHA) | United States | $0.003B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.002B | 0.00 |
| Akanda (AKAN) | Canada | $0.000B | 0.00 |
| InterCure (INCR) | Israel | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.000B | 0.00 |